Gulf International Bank UK Ltd increased its holdings in Iqvia Holdings Inc (NYSE:IQV) by 9.1% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 54,156 shares of the medical research company’s stock after buying an additional 4,500 shares during the period. Gulf International Bank UK Ltd’s holdings in Iqvia were worth $7,026,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Cutler Group LP boosted its position in shares of Iqvia by 173.3% in the 2nd quarter. Cutler Group LP now owns 1,100 shares of the medical research company’s stock worth $109,000 after buying an additional 2,600 shares in the last quarter. Townsend & Associates Inc purchased a new stake in shares of Iqvia in the 2nd quarter worth about $117,000. Fort L.P. purchased a new stake in shares of Iqvia in the 2nd quarter worth about $118,000. Quad Cities Investment Group LLC purchased a new stake in shares of Iqvia in the 2nd quarter worth about $140,000. Finally, Chicago Capital LLC purchased a new stake in shares of Iqvia in the 3rd quarter worth about $221,000. Institutional investors and hedge funds own 91.36% of the company’s stock.
In other news, Director John G. Danhakl sold 370,470 shares of the company’s stock in a transaction dated Wednesday, September 12th. The shares were sold at an average price of $124.83, for a total transaction of $46,245,770.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Kevin C. Knightly sold 9,216 shares of the company’s stock in a transaction dated Friday, September 7th. The shares were sold at an average price of $126.46, for a total transaction of $1,165,455.36. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 601,586 shares of company stock valued at $75,510,422. Corporate insiders own 6.00% of the company’s stock.
NYSE IQV opened at $124.17 on Friday. Iqvia Holdings Inc has a 12 month low of $91.57 and a 12 month high of $135.48. The company has a debt-to-equity ratio of 1.41, a current ratio of 1.09 and a quick ratio of 1.09. The stock has a market cap of $25.62 billion, a PE ratio of 24.97, a P/E/G ratio of 1.82 and a beta of 0.81.
Iqvia (NYSE:IQV) last posted its quarterly earnings data on Monday, October 22nd. The medical research company reported $1.42 EPS for the quarter, beating the Zacks’ consensus estimate of $1.39 by $0.03. Iqvia had a net margin of 12.29% and a return on equity of 13.69%. The company had revenue of $2.59 billion during the quarter, compared to the consensus estimate of $2.58 billion. The business’s quarterly revenue was up 5.2% on a year-over-year basis. On average, analysts expect that Iqvia Holdings Inc will post 5.13 earnings per share for the current fiscal year.
A number of research firms have issued reports on IQV. Zacks Investment Research lowered shares of Iqvia from a “buy” rating to a “hold” rating in a report on Thursday, October 25th. Royal Bank of Canada upped their target price on shares of Iqvia to $137.00 and gave the company an “outperform” rating in a report on Tuesday, October 23rd. Piper Jaffray Companies upped their target price on shares of Iqvia to $131.00 and gave the company a “neutral” rating in a report on Tuesday, October 23rd. Barclays upped their target price on shares of Iqvia from $130.00 to $140.00 and gave the company an “overweight” rating in a report on Tuesday, October 23rd. Finally, UBS Group began coverage on shares of Iqvia in a report on Tuesday, October 9th. They issued a “buy” rating on the stock. Five equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $131.67.
COPYRIGHT VIOLATION WARNING: This news story was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://www.americanbankingnews.com/2018/11/10/gulf-international-bank-uk-ltd-acquires-4500-shares-of-iqvia-holdings-inc-iqv.html.
IQVIA Holdings Inc provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
Featured Article: Day Trading
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.